NOX
NOXOPHARM FPO [NOX]
Healthcare · ASX Small Cap
$0.0640 +6.7%
Updated 26 Mar 2026 · Scores refresh every scan
Score Breakdown
Technical60
Catalyst50
Sentiment50
Fundamental29
Momentum60
Risk Gate43
Get alerts when NOX's score changes
Free watchlist with daily scans for 2,200+ ASX stocks
Active Signals
Bullish Signals
- MACD momentum is picking up steam
- Volume surging at 4.1x normal while price falls — heavy selling pressure
- Beating the Small Ords index — relative strength of 1.10, so it's outpacing the pack
- Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
- Critical cash runway (0.1 quarters)
- Moderate P/S ratio (5.8x)
- Strong revenue growth (+50%)
- Micro-cap ($5-20M) - high risk
- Sentiment is mixed — no strong consensus either way
- Revenue growing at +50% — the top line is moving in the right direction
- The bigger volume days are the up days — volume-weighted momentum is positive (0.62%/day)
- Altman Z-Score grey zone (1.81, low-confidence approx)
- RBA hiking (-3pts)
Risk Signals
- Below the 200-day average — the long-term trend is still working against it
- Piotroski F-Score weak (3/9, low-confidence approx)
- Deeply negative margins (-162%)
- Not enough chatter to gauge sentiment — defaulting to neutral
- Overseas neutral (-2pts, S&P500 neutral, VIX 25)
Ask Scout AI about NOX
3 free messages/day · Unlimited with Pro
Recent Catalysts
NONE Appendix 4D and FY2026 Half Year Financial Report
NONE Notice under Section 708A(5)(e) of the Corps Act
NONE Application for quotation of securities - NOX
Recent ASX Announcements
| 2026-02-27 | Appendix 4D and FY2026 Half Year Financial Report PRICE SENSITIVE |
| 2026-02-26 | Notice under Section 708A(5)(e) of the Corps Act |
| 2026-02-26 | Application for quotation of securities - NOX |
| 2026-02-26 | R&D rebate strengthens cash position PRICE SENSITIVE |
| 2026-02-26 | At-the-Market (ATM) agreement with Acuity Capital PRICE SENSITIVE |
Key Metrics
$19.7M
Market Cap
81K
Avg Volume
4.1x
Vol Ratio
$0.04 — $0.14
52-Week Range
N/A
Short Interest
N/A
Cash Runway
-343.6%
ROE
-161.7%
Profit Margin
CANSLIM Analysis
| Factor | Rating | Detail | |
|---|---|---|---|
| C | Current EPS | fail | EPS Growth: 0% |
| A | Annual Earnings | fail | CAGR: 0% |
| N | New Highs / Catalysts | neutral | |
| S | Supply & Demand | neutral | Float: 64% |
| L | Leader vs Laggard | laggard | RS: -8 |
| I | Institutional Sponsorship | insufficient_data | Inst: 0% |
| M | Market Direction | neutral | Neutral |
Sector: Healthcare
Ranked #27 of 117 · Sector avg: 46
View all Healthcare signals →Track NOX and 2,200+ ASX stocks
Get free access to Scout's AI-powered dashboard with daily scans, watchlist alerts, and conviction scoring for every ASX small cap.
No credit card required